UA93911C2 - Применение бактериального штамма lactobacillus reuteri dsm 17938 для снижения колик у грудных детей - Google Patents
Применение бактериального штамма lactobacillus reuteri dsm 17938 для снижения колик у грудных детейInfo
- Publication number
- UA93911C2 UA93911C2 UAA200813986A UAA200813986A UA93911C2 UA 93911 C2 UA93911 C2 UA 93911C2 UA A200813986 A UAA200813986 A UA A200813986A UA A200813986 A UAA200813986 A UA A200813986A UA 93911 C2 UA93911 C2 UA 93911C2
- Authority
- UA
- Ukraine
- Prior art keywords
- lactobacillus reuteri
- strain dsm
- bacterial strain
- infantile colic
- reducing
- Prior art date
Links
- 208000002881 Colic Diseases 0.000 title abstract 2
- 206010021746 Infantile colic Diseases 0.000 title abstract 2
- 241000186604 Lactobacillus reuteri Species 0.000 title abstract 2
- 229940001882 lactobacillus reuteri Drugs 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 230000000529 probiotic effect Effects 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/446,628 US7374924B2 (en) | 2006-06-05 | 2006-06-05 | Use of selected lactic acid bacteria for reducing infantile colic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA93911C2 true UA93911C2 (ru) | 2011-03-25 |
Family
ID=38790468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200813986A UA93911C2 (ru) | 2006-06-05 | 2007-05-30 | Применение бактериального штамма lactobacillus reuteri dsm 17938 для снижения колик у грудных детей |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US7374924B2 (enExample) |
| EP (1) | EP2040722B1 (enExample) |
| JP (3) | JP4520531B2 (enExample) |
| KR (2) | KR101308865B1 (enExample) |
| CN (2) | CN102488717B (enExample) |
| AU (2) | AU2007200434B2 (enExample) |
| BR (1) | BRPI0710944B8 (enExample) |
| CA (1) | CA2650546C (enExample) |
| DK (1) | DK2040722T3 (enExample) |
| GE (1) | GEP20125480B (enExample) |
| HU (1) | HUE026416T2 (enExample) |
| IL (1) | IL194779A0 (enExample) |
| MX (1) | MX2008014869A (enExample) |
| MY (1) | MY162708A (enExample) |
| NZ (2) | NZ596788A (enExample) |
| RU (1) | RU2435844C2 (enExample) |
| SI (1) | SI2040722T1 (enExample) |
| UA (1) | UA93911C2 (enExample) |
| WO (1) | WO2007142596A1 (enExample) |
| ZA (1) | ZA200809531B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7374924B2 (en) * | 2006-06-05 | 2008-05-20 | Biogaia Ab | Use of selected lactic acid bacteria for reducing infantile colic |
| EP2265135B1 (en) * | 2008-03-14 | 2017-12-20 | Nestec S.A. | Synbiotic mixture |
| AU2014221272B2 (en) * | 2008-11-03 | 2016-01-21 | Société des Produits Nestlé S.A. | A nutritional composition comprising probiotics and improving sleep patterns |
| RU2517616C2 (ru) * | 2008-11-03 | 2014-05-27 | Нестек С.А. | Питательная композиция, включающая пробиотики и улучшающая характер сна |
| US20110104327A1 (en) * | 2009-04-23 | 2011-05-05 | Bacterfield International S.A. | Probiotic pet food |
| SG177541A1 (en) | 2009-07-31 | 2012-02-28 | Nestec Sa | Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients |
| NL2004101C2 (en) * | 2010-01-15 | 2011-07-18 | Friesland Brands Bv | Ruminant il-10 and use in modulating immune response. |
| IT1401460B1 (it) * | 2010-06-11 | 2013-07-26 | Probiotical Spa | "ceppi di batteri probiotici produttori di vitamina b12" |
| KR101706100B1 (ko) * | 2011-12-15 | 2017-02-15 | 삼성전자주식회사 | 성형한계선도 획득용 시험장치 |
| EP2609813A1 (en) * | 2011-12-30 | 2013-07-03 | Nestec S.A. | Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system |
| UA118339C2 (uk) * | 2012-09-03 | 2019-01-10 | Біогайа Аб | Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти) |
| US11179427B2 (en) | 2013-01-21 | 2021-11-23 | Eth Zurich | Baby food composition comprising viable propionic acid-producing bacteria |
| WO2015018883A2 (en) * | 2013-08-09 | 2015-02-12 | Ab-Biotics, S.A. | Probiotic for infantile excessive crying |
| AU2015209763B2 (en) | 2014-01-23 | 2020-12-24 | Biogaia Ab | Selection of agents modulating gastrointestinal pain |
| CN106794207A (zh) * | 2014-10-29 | 2017-05-31 | 雀巢产品技术援助有限公司 | 使用罗伊氏乳杆菌在生命早期恢复微生物群生态失调 |
| EP3294308A4 (en) | 2015-05-14 | 2019-03-06 | University of Puerto Rico | PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN |
| JP6529835B2 (ja) * | 2015-06-23 | 2019-06-12 | 株式会社フィス | 樹状細胞活性化剤 |
| CN105219683B (zh) * | 2015-11-04 | 2018-03-13 | 广东省农业科学院动物科学研究所 | 一株具有益生特征的罗伊氏乳杆菌菌株及其应用 |
| WO2017117142A1 (en) | 2015-12-28 | 2017-07-06 | New York University | Device and method of restoring microbiota of newborns |
| CN106497840B (zh) * | 2016-11-07 | 2019-06-21 | 江南大学 | 一种定向分离免疫调节性肠道乳杆菌的方法 |
| CN117487686A (zh) * | 2018-07-24 | 2024-02-02 | 生命大地女神有限公司 | 选择和使用褪黑素支持细菌以减少婴儿绞痛 |
| MX2020014222A (es) * | 2018-07-24 | 2021-03-09 | Biogaia Ab | Metodos terapeuticos que utilizan cepas bacterianas las cuales son capaces de aumentar los niveles de adenosina. |
| SG11202110355RA (en) * | 2019-04-17 | 2021-11-29 | Biogaia Ab | Therapeutic microvesicles of probiotic bacteria |
| US20240165171A1 (en) * | 2021-03-26 | 2024-05-23 | Seoul National University R&Db Foundation | Composition for enhancing physiological efficacy of lactic acid bacteria |
| CN117925484B (zh) * | 2024-03-19 | 2024-07-09 | 山东中科嘉亿生物工程有限公司 | 一株改善睡眠呼吸暂停的罗伊氏粘液乳杆菌jylb-101及其产品和应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4518696A (en) | 1983-01-11 | 1985-05-21 | Chr. Hansen's Laboratory, Inc. | Stabilized liquid bacterial suspension for oral administration to animals |
| US5413960A (en) | 1987-05-01 | 1995-05-09 | Biogaia Ab | Antibiotic reuterin |
| US5458875A (en) | 1990-06-15 | 1995-10-17 | Biogaia Ab | In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry |
| US5534253A (en) | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
| AU718040B2 (en) | 1995-12-21 | 2000-04-06 | Abbott Laboratories | Use of lactobacillus reuteri to inhibit cryptosporidiosis in mammals |
| US5837238A (en) | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
| US5800813A (en) | 1996-11-12 | 1998-09-01 | Biogaia Biologics Ab | Treatment of cryptosporidium infections |
| KR19990024297A (ko) | 1997-08-07 | 1999-04-06 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
| US6100388A (en) | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| EP1034788A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactic acid bacteria strains capable of preventing diarrhea |
| EP1344458A1 (en) * | 2002-03-12 | 2003-09-17 | Société des Produits Nestlé S.A. | Probiotic delivery system |
| EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| US7105336B2 (en) | 2002-10-07 | 2006-09-12 | Biogaia Ab | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| EP1567018B1 (en) * | 2002-10-18 | 2009-07-01 | Biogaia Ab | Method of improving immune function in mammals using lactobacillus reuteri strains |
| US20040208863A1 (en) | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
| US20040185032A1 (en) | 2003-03-18 | 2004-09-23 | David Burrell | Compositions and methods for treating colic |
| EP1638414B1 (en) * | 2003-06-23 | 2009-06-17 | Nestec S.A. | Infant or follow-on formula |
| US7955834B2 (en) * | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
| US20060251634A1 (en) * | 2005-05-06 | 2006-11-09 | Ho-Jin Kang | Method of improving immune function in mammals using lactobacillus strains with certain lipids |
| US8603460B2 (en) * | 2006-06-05 | 2013-12-10 | Brogaia AB | Method of making a Lactobacillus reuteri with increased acid tolerance |
| US7374924B2 (en) * | 2006-06-05 | 2008-05-20 | Biogaia Ab | Use of selected lactic acid bacteria for reducing infantile colic |
-
2006
- 2006-06-05 US US11/446,628 patent/US7374924B2/en active Active
-
2007
- 2007-02-01 AU AU2007200434A patent/AU2007200434B2/en active Active
- 2007-05-30 JP JP2009514239A patent/JP4520531B2/ja active Active
- 2007-05-30 MY MYPI20071631A patent/MY162708A/en unknown
- 2007-05-30 KR KR1020107012584A patent/KR101308865B1/ko active Active
- 2007-05-30 CA CA2650546A patent/CA2650546C/en active Active
- 2007-05-30 NZ NZ596788A patent/NZ596788A/xx not_active IP Right Cessation
- 2007-05-30 GE GEAP200711000A patent/GEP20125480B/en unknown
- 2007-05-30 EP EP07748532.4A patent/EP2040722B1/en active Active
- 2007-05-30 UA UAA200813986A patent/UA93911C2/ru unknown
- 2007-05-30 CN CN201110432103.1A patent/CN102488717B/zh active Active
- 2007-05-30 KR KR1020087026182A patent/KR101030661B1/ko active Active
- 2007-05-30 BR BRPI0710944A patent/BRPI0710944B8/pt active IP Right Grant
- 2007-05-30 CN CN2007800012187A patent/CN101374533B/zh active Active
- 2007-05-30 NZ NZ572359A patent/NZ572359A/en unknown
- 2007-05-30 DK DK07748532.4T patent/DK2040722T3/en active
- 2007-05-30 SI SI200731741T patent/SI2040722T1/sl unknown
- 2007-05-30 MX MX2008014869A patent/MX2008014869A/es active IP Right Grant
- 2007-05-30 HU HUE07748532A patent/HUE026416T2/en unknown
- 2007-05-30 RU RU2008147883/10A patent/RU2435844C2/ru active
- 2007-05-30 WO PCT/SE2007/050371 patent/WO2007142596A1/en not_active Ceased
- 2007-05-30 ZA ZA200809531A patent/ZA200809531B/xx unknown
- 2007-10-29 US US11/978,417 patent/US9057112B2/en active Active
-
2008
- 2008-10-22 IL IL194779A patent/IL194779A0/en active IP Right Grant
-
2010
- 2010-04-14 JP JP2010092728A patent/JP2010202654A/ja active Pending
- 2010-07-14 AU AU2010202976A patent/AU2010202976B2/en active Active
-
2012
- 2012-01-23 US US13/355,585 patent/US9340840B2/en active Active
-
2013
- 2013-03-27 JP JP2013065540A patent/JP5865283B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA93911C2 (ru) | Применение бактериального штамма lactobacillus reuteri dsm 17938 для снижения колик у грудных детей | |
| UA111715C2 (uk) | Композиція, що містить пробіотичні бактерії для застосування у лікуванні імунних розладів | |
| EP1634600A4 (en) | ANTIALLERGIC COMPOSITION | |
| KR100479719B1 (ko) | 유해 병원성 미생물 생육 억제능 및 항알레르기성을 갖는 신규 내산성 락토바실러스 사케이 Ｐｒｏｂｉｏ-65 | |
| WO2007085970A3 (en) | Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders | |
| AU2004241895B2 (en) | A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and a fiber fermenting property | |
| AU2002258275A1 (en) | Novel lactobacillus sp. strain and use thereof | |
| WO2009138091A3 (en) | Isolated microorganism strain lactobacillus plantarum tensia dsm 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product | |
| WO2003033681A3 (en) | Composition comprising a lactobacillus pentosus strain and uses thereof | |
| UA101316C2 (ru) | Применение отобранных молочнокислых бактерий для профилактики и лечения атеросклероза | |
| UA93542C2 (ru) | Штамм молочнокислых бактерий streptococcus thermophilus, который обеспечивает улучшенную текстуру ферментированных продуктов | |
| ATE367821T1 (de) | Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung | |
| AR038036A1 (es) | Nueva cepa de bacterias del acido lactico y composiciones comestibles, drogas y productos veterinarios que la contienen | |
| PL1784085T3 (pl) | Szczepy wytwarzające esterazę ferulanową i sposoby ich zastosowania | |
| GB0513556D0 (en) | Product | |
| MXPA04004252A (es) | Del genero bifidobacterium y alimentos fermentados que utilizan la misma. | |
| UA94056C2 (uk) | Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій | |
| AP1563A (en) | Lactic acid bacteria for the treatment and /or prophylaxis of giardiasis. | |
| FI20030258A0 (fi) | Glukosinolaattien entsymaattisen hajottamisen ohjaaminen maitohappobakteerien avulla | |
| SG132618A1 (en) | Bacterial culture having effects of suppressing dermatities development and accelerating skin wound healing, and product using the same | |
| JP4966679B2 (ja) | 乳酸菌およびこれを用いる製麹方法 | |
| WO2009139655A3 (en) | The use of an exopolysaccharide fraction produced by Lactobacillus rhamnosus | |
| PL1724340T3 (pl) | Szczepy bakterii kwasu mlekowego wrażliwe na antybiotyk | |
| Aderiye et al. | In vivo evaluation of hypolipidemic potentials of Bacillus species isolated from fermented locust bean (Parkia fillicoides Welw) seeds (Iru). | |
| Saravanan | Diversity And Functional Characterization Of Microflora Isolated From Idli Batter |